|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.270 USD | -0.61% |
|
+1.24% | -9.42% |
| 08-12 | Altimmune, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-12 | Altimmune, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALT | Delayed | |
CBOE
| ALT | Real-time | |
Tradegate
| 3G0 | Real-time | |
Boerse Muenchen
| 3G0 | Real-time | |
Mexican S.E.
| ALT1 * | End-of-day quote | |
Deutsche Boerse AG
| 3G0 | Delayed | |
Börse Stuttgart
| 3G0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 3.42 | 3.62 | 3.83 |
| Spread/Res. | -4.39% | -9.67% | -14.62% |
| Spread/Supp. | +5.83% | +26.25% | +25.29% |
| Support | 3.09 | 2.59 | 2.61 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALT Stock
- Charts Altimmune, Inc.
Select your edition
All financial news and data tailored to specific country editions

















